Sign in

Trial site

CHU Montpellier Lapeyronie Hospital

Montpellier, 34295, FranceNot linked to an institution yet
  • 2running trials

The trials here

What the 2 trials at this site are about, from their registry records.

Phase
  • Phase 21 trial
  • Phase 31 trial
Status
  • Active, not recruiting2 trials
Lead sponsor
  • Eli Lilly and Company1 trial
  • Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Running trials

Site data: ClinicalTrials.govUpdated 12 Nov 2026

CHU Montpellier Lapeyronie Hospital: trial site – Frontlight Research